Intravenous magnesium sulfate before preterm birth at 30 to 34 weeks of gestation does not improve child survival free of cerebral palsy, according to a study published in the Aug. 15 issue of the Journal of the American ...
Aug 17, 2023
0
1
How well can we assess the strength of our own immune system? The answer is that we are surprisingly good at this. A study by Konstanz psychologist Stephanie Dimitroff examined how freshly vaccinated people assess the strength ...
Aug 16, 2023
0
1
Treatment with modern antidepressants may help prevent patients with bipolar disorder from relapsing into a depressive episode, according to an international clinical trial led by researchers at the University of British ...
Aug 2, 2023
0
1
Road safety is a critical issue in an era of increasing cannabis legalization. Cannabis is known to impair reaction time, decision-making, coordination and perception—skills necessary for safe driving. In the last three ...
Aug 2, 2023
0
1
Maintenance therapy with selinexor provides durable survival benefits for endometrial cancer with TP53 mutations, according to a study presented during the July 2023 session of the American Society for Clinical Oncology Plenary ...
Jul 28, 2023
0
1
For patients with narcolepsy type 1, an orexin receptor 2 agonist, TAK-994, improves measures of sleepiness and cataplexy over eight weeks compared with placebo but is associated with hepatotoxic adverse events, according ...
Jul 27, 2023
0
11
Anxiety disorders are common among Australian children, affecting nearly 7% of those aged 4–11 years.
Jul 24, 2023
0
6
For patients with refractory metastatic colorectal cancer, fruquintinib treatment yields a significant and clinically meaningful benefit in terms of overall survival, according to a study published in the July 1 issue of ...
Jul 20, 2023
0
1
For patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in the New England Journal of Medicine to coincide with the annual Alzheimer's Association ...
Jul 19, 2023
0
1
Janus kinase (JAK) inhibitors are associated with more hair regrowth than placebo for patients with alopecia areata, according to a review published online June 27 in JAMA Network Open.
Jul 19, 2023
0
17
